CASE REPORT
Accepted on 11 Apr 2025
Acquired ROS1 Fusion and Iruplinalkib Response in Advanced NSCLC after Multiple Lines of Systematic Therapy: A Case Report
doi 10.3389/fonc.2025.1571512
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advancing NSCLC Treatment: Overcoming Challenges in Immune Checkpoint Inhibitor Therapy
Advancing NSCLC Treatment: Overcoming Challenges in Immune Checkpoint Inhibitor Therapy
1,922
Total downloads
7,756
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 08 Apr 2025
Adjuvant immunotherapy improves survival in completely resected stage IB–III NSCLC: a systematic review and meta-analysis
doi 10.3389/fonc.2025.1493221
- 216 views
ORIGINAL RESEARCH
Published on 03 Apr 2025
From COPD to cancer: indacaterol’s unexpected role in combating NSCLC
doi 10.3389/fphar.2025.1579126
- 211 views
MINI REVIEW
Published on 21 Mar 2025
The distinct roles of IL-37 and IL-38 in non-small cell lung carcinoma and their clinical implications
doi 10.3389/fimmu.2025.1564357
- 490 views
METHODS
Published on 17 Mar 2025
Association between CONUT scores and survival outcomes in patients with non-small cell lung cancer: meta-analysis from 4973 Asian cases
doi 10.3389/fonc.2025.1522368
- 283 views
CASE REPORT
Published on 06 Mar 2025
Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report
doi 10.3389/fonc.2025.1498701
- 474 views
ORIGINAL RESEARCH
Published on 20 Feb 2025
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis
doi 10.3389/fonc.2025.1526931
- 908 views
CASE REPORT
Published on 23 Jan 2025
Pulmonary enteric adenocarcinoma with progression disease after second - line therapy: a case report
doi 10.3389/fonc.2025.1509026
- 550 views
ORIGINAL RESEARCH
Published on 23 Jan 2025
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
doi 10.3389/fonc.2025.1533556
- 498 views
CASE REPORT
Published on 11 Oct 2024
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report
doi 10.3389/fonc.2024.1431971
- 1,335 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: